Literature DB >> 8223071

Very low intraluminal colonic pH in patients with active ulcerative colitis.

J Fallingborg1, L A Christensen, B A Jacobsen, S N Rasmussen.   

Abstract

Intraluminal gastrointestinal pH was measured in seven patients with active ulcerative colitis (four male, three female). A radiotelemetry capsule was used, and its location was determined by fluoroscopy. Satisfactory measurements were obtained from six, in all of whom pH levels were normal in the stomach and small intestine. Three patients also had normal pH values in the colon. However, in the remaining three patients very low pH levels (lowest values 2.3, 2.9, and 3.4) were found in the proximal parts of the colon. Five of the seven patients, including the three with low pH in the colon, underwent colectomy. The mechanism behind the low intraluminal pH in some patients with ulcerative colitis is speculative. Increased fecal concentrations of lactate occur in active disease, but some of the pH values measured in our study were below the pKa value of lactate. The study demonstrates that very low intraluminal pH levels in the colon occur in some patients with active ulcerative colitis. This might be an indicator of severe activity of the disease.

Entities:  

Mesh:

Year:  1993        PMID: 8223071     DOI: 10.1007/bf01297074

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

1.  pH-profile and regional transit times of the normal gut measured by a radiotelemetry device.

Authors:  J Fallingborg; L A Christensen; M Ingeman-Nielsen; B A Jacobsen; K Abildgaard; H H Rasmussen
Journal:  Aliment Pharmacol Ther       Date:  1989-12       Impact factor: 8.171

2.  A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis.

Authors:  V Binder
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

3.  Risk factors in toxic megacolon.

Authors:  R Caprilli; P Vernia; O Colaneri; G Frieri
Journal:  Dig Dis Sci       Date:  1980-11       Impact factor: 3.199

4.  An accurate, long-term, pH-sensitive radio pill for ingestion and implantation.

Authors:  R H Colson; B W Watson; P D Fairclough; J A Walker-Smith; C A Campbell; D Bellamy; S M Hinsull
Journal:  Biotelem Patient Monit       Date:  1981

5.  Colonic bicarbonate output as a test of disease activity in ulcerative colitis.

Authors:  W E Roediger; M J Lawson; V Kwok; A K Grant; P R Pannall
Journal:  J Clin Pathol       Date:  1984-06       Impact factor: 3.411

6.  Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device.

Authors:  R L Bown; J A Gibson; G E Sladen; B Hicks; A M Dawson
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

7.  Fecal lactate and ulcerative colitis.

Authors:  P Vernia; R Caprilli; G Latella; F Barbetti; F M Magliocca; M Cittadini
Journal:  Gastroenterology       Date:  1988-12       Impact factor: 22.682

8.  Utilization of nutrients by isolated epithelial cells of the rat colon.

Authors:  W E Roediger
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

9.  The colonic epithelium in ulcerative colitis: an energy-deficiency disease?

Authors:  W E Roediger
Journal:  Lancet       Date:  1980-10-04       Impact factor: 79.321

  9 in total
  37 in total

1.  Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease.

Authors:  K Ewe; S Schwartz; S Petersen; A G Press
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

Review 2.  ["Targeted delivery" in the gastrointestinal tract].

Authors:  C S Leopold
Journal:  Med Klin (Munich)       Date:  1999-02-15

3.  Pharmacological inhibition of GPR4 remediates intestinal inflammation in a mouse colitis model.

Authors:  Edward J Sanderlin; Mona Marie; Juraj Velcicky; Pius Loetscher; Li V Yang
Journal:  Eur J Pharmacol       Date:  2019-03-28       Impact factor: 4.432

4.  Mechanism of regulation of Na-H exchanger in inflammatory bowel disease: role of TLR-4 signaling mechanism.

Authors:  Iqbal Siddique; Islam Khan
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

5.  Structural and functional analysis of four family 84 glycoside hydrolases from the opportunistic pathogen Clostridium perfringens.

Authors:  Benjamin Pluvinage; Patricia M Massel; Kristyn Burak; Alisdair B Boraston
Journal:  Glycobiology       Date:  2019-12-12       Impact factor: 4.313

Review 6.  Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs.

Authors:  S G Nugent; D Kumar; D S Rampton; D F Evans
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

7.  Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease.

Authors:  Sufeng Zhang; Robert Langer; Giovanni Traverso
Journal:  Nano Today       Date:  2017-10-09       Impact factor: 20.722

Review 8.  Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity.

Authors:  Mehrbod Estaki; Daniella DeCoffe; Deanna L Gibson
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

9.  GPR4 deficiency alleviates intestinal inflammation in a mouse model of acute experimental colitis.

Authors:  Edward J Sanderlin; Nancy R Leffler; Kvin Lertpiriyapong; Qi Cai; Heng Hong; Vasudevan Bakthavatchalu; James G Fox; Joani Zary Oswald; Calvin R Justus; Elizabeth A Krewson; Dorcas O'Rourke; Li V Yang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-12-07       Impact factor: 5.187

10.  Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA.

Authors:  Wycliffe S Omwancha; Rama Mallipeddi; Brenda L Valle; Steven H Neau
Journal:  Int J Pharm       Date:  2012-11-28       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.